Mobia Medical (NASDAQ:MOBI) CFO Nelson Bunker Curnes Purchases 5,000 Shares of Stock

Mobia Medical, Inc. (NASDAQ:MOBI – Get Free Report) CFO Nelson Bunker Curnes acquired 5,000 shares of the firm’s stock in a transaction on Tuesday, June 9th. The shares were acquired at an average price of $12.79 per share, with a total value of $63,950.00. Following the completion of the purchase, the chief financial officer owned 366,997 shares in the company, valued at approximately $4,693,891.63. This trade represents a 1.38% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link.

Mobia Medical Stock Down 3.1%

Shares of NASDAQ MOBI opened at $12.32 on Friday. Mobia Medical, Inc. has a 12 month low of $10.19 and a 12 month high of $14.77. The company has a market cap of $409.63 million, a price-to-earnings ratio of 66.00 and a beta of 2.84.

Get Mobia Medical alerts:

Mobia Medical (NASDAQ:MOBI – Get Free Report) last announced its quarterly earnings data on Thursday, June 4th. The company reported $999.00 EPS for the quarter. The business had revenue of $12.07 million for the quarter.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on MOBI. Wolfe Research began coverage on shares of Mobia Medical in a report on Tuesday, June 2nd. They issued an “outperform” rating for the company. JPMorgan Chase & Co. started coverage on shares of Mobia Medical in a report on Tuesday, June 2nd. They set an “overweight” rating and a $15.00 target price for the company. Bank of America started coverage on shares of Mobia Medical in a report on Tuesday, June 2nd. They set a “buy” rating and a $16.00 target price for the company. Wall Street Zen lowered shares of Mobia Medical from a “hold” rating to a “sell” rating in a report on Saturday, June 6th. Finally, Zacks Research raised shares of Mobia Medical to a “hold” rating in a report on Wednesday, June 3rd. Five research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $20.25.

Get Our Latest Report on MOBI

Featured Articles

• Five stocks we like better than Mobia Medical
• Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
• NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
• The World Cup Is Coming—These 3 Stocks Could Cash In
• Spotify’s “North Star” Outlook Was Music to Investors Ears

Receive News & Ratings for Mobia Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mobia Medical and related companies with MarketBeat.com's FREE daily email newsletter.